Ceftazidime/avibactam
Ceftazidime/avibactam is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Complicated intra-abdominal infection (cIAI) in combination with metronidazole
- Complicated urinary tract infection (cUTI) including pyelonephritis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Resistant Gram-negative infections including ESBL-producing and certain carbapenemase-producing (KPC only) bacteria
- Trials are currently underway for the management of hospital-acquired and/or ventilator-associated pneumonia
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Complicated intra-abdominal infection (cIAI) in combination with metronidazole
- Complicated urinary tract infection (cUTI) including pyelonephritis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Resistant Gram-negative infections including ESBL-producing and certain carbapenemase-producing (KPC only) bacteria
- Trials are currently underway for the management of hospital-acquired and/or ventilator-associated pneumonia
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved